Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-088589

ACURA PHARMACEUTICALS, INC · ACUR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jan 4, 2016
Accepted (ET)
Jan 5, 2016 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000786947

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3,F4Jan 4, 2016M8,074—A10,830D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF4,F2,F6,F5—Jan 4, 2016D3,460D——Common Stock3,46010,524D
Restricted Stock UnitsF4,F2,F5—Jan 4, 2016M8,074D——Common Stock8,0742,450D
Restricted Stock UnitsF8,F2,F7—Jan 4, 2016A22,026A——Common Stock22,02624,476D

Explanation of responses